会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • MOISTURIZING AGENT
    • 滋润剂
    • US20110129434A1
    • 2011-06-02
    • US12991835
    • 2009-04-27
    • Mitsuaki GotoMasamichi IwamaYumi Anan
    • Mitsuaki GotoMasamichi IwamaYumi Anan
    • A61K31/74A61Q1/00C08F12/08
    • A61K31/702A61K8/8111A61K8/8117A61K8/8129A61Q19/08
    • Disclosed is a moisturizing agent comprising a copolymer represented by formula (1). [In formula (1), A represents a substituent containing an oligosaccharide composed of 2 to 6 monosaccharide molecules bound to each other; B represents a group represented by formula (2); m and n represent numbers which meet the following equation m:n=9:1 to 1:9; and Z represents a hydrogen group, a methyl group or an ethyl group.] [In formula (2), X represents a saturated or unsaturated monocyclic or dicyclic ring having 5 to 10 ring-constituting members, or a molecule containing a nitrogen or an oxygen, provided that the ring may contain 1 to 3 atoms independently selected from the group consisting of a nitrogen, a sulfur and an oxygen; n represents a number of 0 or 1; Y represents —NHCO—, —CONH—, —NHCONH—, —NH—, —CO, or an alkyl group having 0 or more carbon atoms; and R represents a linear or branched alkyl, alkenyl or alkynyl having 1 to 20 carbon atoms which, if required, may be substituted by one or two hydroxy, mercapto, amino, cyano, heterocyclyl, heterocyclyloxy, phenyl, benzyl, heteroaryl, phenoxy, benzyloxy or heteroaryloxy groups.]
    • 公开了包含由式(1)表示的共聚物的保湿剂。 [式(1)中,A表示含有由相互结合的2〜6个单糖分子构成的寡糖的取代基。 B表示式(2)表示的基团。 m和n表示满足以下等式m的数:n = 9:1至1:9; Z表示氢原子,甲基或乙基。] [式(2)中,X表示具有5〜10个环构成成分的饱和或不饱和的单环或双环,或含有氮或 氧,条件是环可以含有1-3个独立地选自氮,硫和氧的原子; n表示0或1的数; Y表示-NHCO-,-CONH-,-NHCONH-,-NH-,-CO或具有0个或更多个碳原子的烷基; 并且R表示具有1至20个碳原子的直链或支链烷基,烯基或炔基,如果需要,其可以被一个或两个羟基,巯基,氨基,氰基,杂环基,杂环基氧基,苯基,苄基,杂芳基,苯氧基, 苄氧基或杂芳氧基。
    • 5. 发明授权
    • Adoptive immune cells for tumor vaccines
    • 免疫细胞用于肿瘤疫苗
    • US07655393B2
    • 2010-02-02
    • US11579280
    • 2004-05-11
    • Kenichiro HasumiAkira ImaizumiMasamichi IwamaMitsuaki Goto
    • Kenichiro HasumiAkira ImaizumiMasamichi IwamaMitsuaki Goto
    • A01N1/02
    • C12N5/0068A61K2039/5154C12N2533/70
    • The present invention provides a method for preparing adoptive immune cells comprising the following steps of a) obtaining mammalian antigen-presenting associated cells; b) culturing the resulting cells in a culture vessel coated with a sugar chain-containing polymer; and c) detaching the cells by shaking the culture vessel without treating the cells with enzyme and without using a cell detaching tool; adoptive immune cells obtained by this preparing method; a culture vessel coated with a sugar chain-containing polymer for use in this preparation method; a kit for preparing an adoptive immune cell vaccine; and a method and a medicine for treating a malignant tumor, type I diabetes, atopic allergic diseases or infections using the adoptive immune cells.
    • 本发明提供一种制备过继免疫细胞的方法,包括以下步骤:a)获得哺乳动物抗原呈递相关细胞; b)将所得细胞培养在涂有含糖链的聚合物的培养容器中; 和c)通过摇动培养容器而不用酶处理细胞并且不使用细胞分离工具来分离细胞; 通过该制备方法获得的过继免疫细胞; 用该制备方法使用的含糖链聚合物的培养容器; 用于制备过继性免疫细胞疫苗的试剂盒; 以及使用过继免疫细胞治疗恶性肿瘤,I型糖尿病,特应性过敏性疾病或感染的方法和药物。
    • 6. 发明授权
    • Adoptive immune cells for tumor vaccines
    • 免疫细胞用于肿瘤疫苗
    • US08075882B2
    • 2011-12-13
    • US12653090
    • 2009-12-08
    • Kenichiro HasumiAkira ImaizumiMasamichi IwamaMitsuaki Goto
    • Kenichiro HasumiAkira ImaizumiMasamichi IwamaMitsuaki Goto
    • A61K35/12C12N5/07
    • C12N5/0068A61K2039/5154C12N2533/70
    • Adoptive immune cells obtained by a method including (a) obtaining mammalian antigen-presenting associated cells; (b) culturing the resulting cells from step (a) in a culture liquid contained in a culture vessel coated with a sugar chain-containing polymer; and (c) detaching the cells from step (b) by shaking the culture vessel without treating the cells with an enzyme and without using a cell detaching tool. A method for treating a malignant tumor, type I diabetes, an atopic allergic disease or an infection, by administering the adoptive immune cells to a patient. A pharmaceutical composition for treating a malignant tumor, type I diabetes, an atopic allergic disease or an infection, including the adoptive immune cells and a pharmaceutically acceptable carrier.
    • 通过包括(a)获得哺乳动物抗原呈递相关细胞的方法获得的免疫免疫细胞; (b)从包含在含有糖链的聚合物的培养容器中的培养液中培养来自步骤(a)的所得细胞; 和(c)通过摇动培养容器从步骤(b)中分离细胞而不用酶处理细胞,而不使用细胞分离工具。 通过向患者施用过继免疫细胞来治疗恶性肿瘤,I型糖尿病,特应性过敏性疾病或感染的方法。 用于治疗恶性肿瘤,I型糖尿病,特应性过敏性疾病或感染的药物组合物,包括过继免疫细胞和药学上可接受的载体。